Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry

Neal G Uren1, S P Schwarzacher, J A Metz

  • 1Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, U.S.A.

European Heart Journal
|January 12, 2002
PubMed

Insights

Intravascular ultrasound (IVUS) identified abnormalities in most stents linked to stent thrombosis, significantly more than angiography alone. IVUS provides crucial predictive information for stent thrombosis risk.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Stent thrombosis remains a serious complication following coronary stenting.
  • Predictive markers for stent thrombosis are crucial for improving patient outcomes.
  • Intracoronary imaging modalities like intravascular ultrasound (IVUS) may offer enhanced insights beyond standard angiography.

Purpose of the Study:

  • To evaluate the utility of intravascular ultrasound (IVUS) in predicting stent thrombosis.
  • To compare the diagnostic yield of IVUS versus angiography in identifying abnormalities associated with stent thrombosis.

Main Methods:

  • A retrospective multicentre registry enrolled 53 patients who experienced stent thrombosis after IVUS-guided stent deployment.
  • Patient demographics, clinical presentation, procedural details, and IVUS findings were analyzed.
  • Angiographic findings were compared with IVUS findings for abnormalities such as under-expansion, malapposition, and thrombus.

Main Results:

  • 94% of stents associated with thrombosis showed at least one abnormality on IVUS (under-expansion, malapposition, etc.).
  • Angiography detected abnormalities in only 32% of these cases (P<0.001).
  • Stent thrombosis occurred at a median of 132 hours post-deployment, with high rates of myocardial infarction (67%) and mortality (15%).

Conclusions:

  • Intravascular ultrasound is superior to angiography in detecting stent abnormalities predictive of thrombosis.
  • IVUS provides critical information at the time of stent deployment to identify high-risk stents.
  • Routine use of IVUS may help mitigate the risk of stent thrombosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...